Revenue for DOC has generally increased year-over-year, marked by quarterly fluctuations. Margins have compressed occasionally due to spikes in costs and other expenses, but operating income remains positive. EBITDA ratios have hovered around mid-40% to 70%, indicating reasonable operational leverage.

Revenue growth is supported by lease escalations and a stable occupancy rate in healthcare properties. While the Q2 2026 revenue of approximately $771 million represents modest growth versus prior quarters, cost of revenue variability impacts gross profit consistency.

Gross profit margins are inconsistent, showing occasional negative values in some quarters due to expense timing or asset sales, but mostly average above 50%. Operating margins fluctuate between 15% and 20%, reflecting tight control over general and administrative expenses despite elevated other expenses.

Earnings quality shows volatility driven by other expenses and interest costs, resulting in swings in net income and EPS quarter to quarter. Nevertheless, positive operating cash flows and EBITDA margins suggest underlying earnings are supported by core operations rather than one-offs.

On a year-over-year basis, revenue has grown from roughly $695 million in mid-2024 quarters to approximately $770 million by mid-2026, reflecting around a 10.7% increase over two years. Sequential quarter growth is modest, with Q2 2026 revenue up about 2.5% QoQ from Q1 2026.

Earnings per share have shown notable volatility, with EPS rising from about $0.06 in early 2025 to a peak of $0.28 in Q1 2026 before dropping to $0.08 in Q2 2026. The overall EPS trajectory is positive but uneven, affected by expense fluctuations.

Revenue growth is driven by a growing tenant base in healthcare properties, rent escalations, and portfolio expansion or acquisitions. The aging population and increasing healthcare demand underpin long-term growth potential.

Growth is primarily organic, supported by lease renewals and operational efficiencies, with some support from asset management strategies. Acquisitions and capital deployment impact cost structure, influencing earnings quality.

Gross margins hover around 55%-60% on average but can be negative in some quarters due to unusual expense recognition. Operating margins remain between 15%-20%, exhibiting some pressure from other expenses and interest costs.

Net income margins are typically below 10%, reflecting REIT tax structures and interest pressures. ROE and ROA data are not available, but operating margins and EBITDA margins over 45% indicate decent profitability.

Margins face risks from rising interest rates and increased costs, but the essential nature of the healthcare real estate portfolio supports margin stability over time.